Hisamitsu Pharmaceutical Co., Inc.
Hisamitsu Pharmaceutical Co., Inc. (HTSUF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
htsuf · pe ratio · data through Jun 10, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Hisamitsu Pharmaceutical Co., Inc.You HTSUF | $2.0B | 22.30x | -70.9% | $270.90 |
 Fagron N.V. ARSUF | $1.9B | 16.06x | -79.0% | $1.25 |
 BioArctic AB (publ) BRCTF | $3.1B | 27.80x | -63.7% | $11.52 |
 CanSino Biologics Inc. CASBF | $1.4B | 309.29x | +304.2% | $0.11 |
 China Medical System Holdings Limited CHSYF | $2.3B | 15.75x | -79.4% | $0.60 |
 Curaleaf Holdings, Inc. CURLF | $3.0B | N/A | — | -$0.93 |
 Dermapharm Holding SE DMPHF | $2.9B | 13.70x | -82.1% | $2.46 |
Industry Average 5 peers with valid PE | — | 76.52x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Hisamitsu Pharmaceutical Co., Inc. (HTSUF) measures how much investors pay for each dollar of the company's trailing earnings. HTSUF's current PE ratio of 22.30x is calculated by dividing its stock price of $29.00 by its TTM earnings per share of $270.90.
Frequently asked questions
HTSUF pe ratio · 6 questionsHTSUF's current PE ratio is 22.30x as of 2026-06-10, based on a stock price of $29.00 and TTM EPS of $270.90. Data sourced from Financial Modeling Prep via HTSUF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Hisamitsu Pharmaceutical Co., Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-10